Development and Management of Registry in Patients With Gynecologic Cancer in Korea

Recruiting

• Conditions: Endometrial Cancer; Peritoneal Cancer; Ovarian Cancer; Fallopian Tube Cancer; Cervical Cancer
• Interventions: Other: Patient registry

• Registration Number: NCT05912972
• Lead Sponsor: Asan Medical Center

Brief Summary

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.

Detailed Description

Cervical cancer, endometrial cancer, and ovarian cancer represent gynecologic cancers. There are many open issues that need to be addressed, specifically the surgical method, disease recurrence and survival outcome in the so called "real world" setting. The aim of this observational study is to collect both retrospective and prospective medical information of gynecologic cancer patients.

Study Timeline

• Study Start: 2022-10-21
• Status Verified: 2023-06
• Study First Submitted: 2023-06-12
• Study First Submitted QC: 2023-06-12
• Last Update Submitted: 2023-06-12
• Study First Posted: 2023-06-22
• Last Update Posted: 2023-06-22
• Primary Completion: 2027-10-21
• Study Completion: 2027-10-21

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 13500

Inclusion Criteria

• Female patients 18 years or older
• Written informed consent (prospective cohort)
• Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

Exclusion Criteria

• Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cervical cancer	Patient registry	No interventions
Endometrial cancer	Patient registry	No interventions
Ovarian cancer, Fallopian tube cancer, Peritoneal cancer	Patient registry	No interventions

Primary Outcome Measures

Name	Time	Method
Overall survival	5 years	Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to baseline characteristics, surgical methods, and treatment

Secondary Outcome Measures

Name	Time	Method
Progression-free survival	5 years	Analyzed for all patients, as time from diagnosis to progression of disease or death as a result of any cause, stratified according to baseline characteristics, surgical methods, and treatment

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center; 🇰🇷 Seoul, Korea, Republic of